Skip NavigationSkip to Content

A potential role for imaging technology in anticancer efficacy evaluations

  1. Author:
    Hollingshead, M. G.
    Bonomi, C. A.
    Borgel, S. D.
    Carter, J. P.
    Shoemaker, R.
    Melillo, G.
    Sausville, E. A.
  2. Author Address

    Hollingshead, MG, NCI, Dev Therapeut Program, Div Canc Diagnosis & Treatment, Bethesda, MD 20892 USA NCI, Dev Therapeut Program, Div Canc Diagnosis & Treatment, Bethesda, MD 20892 USA. SAIC Frederick Inc, Ft Detrick, MD 21702 USA.
    1. Year: 2004
  1. Journal: European Journal of Cancer
    1. 40
    2. 6
    3. Pages: 890-898
  2. Type of Article: Article
  1. Abstract:

    The introduction of imaging methods suitable for rodents offers opportunities for new anticancer efficacy models. Traditional models do not provide the level of sensitivity afforded by these precise and quantitative techniques. Bioluminescent endpoints, now feasible because of sensitive charge-coupled device cameras, can be non-invasively detected in live animals. Currently, the most common luminescence endpoint is firefly luciferase, which, in the presence of O-2 and ATP, catalyses the cleavage of the substrate luciferin and results in the emission of a photon of light. In vivo implantation of tumour cells transfected with the luciferase gene allows sequential monitoring of tumour growth within the viscera by measuring these photon signals. Furthermore, tumour cell lines containing the luciferase gene transcribed from an inducible promoter offer opportunities to study molecular-target modulation without the need for ex vivo evaluations of serial tumour samples. In conjunction with this, transgenic juice bearing a luciferase reporter mechanism can be used to monitor the tumour microenvironment as well as to signal when transforming events occur. This technology has the potential to reshape the efficacy evaluations and drug-testing algorithms of the future. Published by Elsevier Ltd

    See More

External Sources

  1. No sources found.

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel